Liuqing Yang

机构：The University of Texas MD Anderson Cancer Center, Henan University of Traditional Chinese Medicine, Southern University of Science and Technology, NeuroDevelopment Center, Scripps MD Anderson Cancer Center, First Affiliated Hospital of Henan University · ORCID：0000-0002-6518-474X

发表论文 187 篇 · 总被引 8886 次 · h-index 40

代表论文

• Immune cell lncRNAs reprogram the tumor microenvironment (2026 · Trends in Cell Biology · 被引 1)
• Supplementary Table S8 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
• Supplementary Appendix S1 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
• Supplementary Table S3 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
• Supplementary Figure S4 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)
• Supplementary File S1 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma (2026)